In view of the poor aqueous solubility of nifluminic acid (NIF), the aim of this article was to improve its solubility and dissolution rate through the preparation of formulations based on hydroxypropyl β-cyclodextrin (HPβCD) and polyvinylpyrrolidone K25 (PVP K25), a combination of carriers which has been advantageously used for a similar purpose with various hydrophobic drugs. Ternary systems of NIF, HPβCD, and PVP K25 were prepared in different drug to CD to PVP ratios by physical mixing, kneading, microwave irradiation, and co-evaporation. Differential scanning calorimetry, thermogravimetric analysis, hot stage microscopy, Fourier transform infrared spectroscopy, and X-ray powder diffractometry were used to investigate the resulting solid-state interactions. The results showed that the solid state of the drug in the amorphous or crystalline ternary combinations influenced both the solubility and the dissolution rate of NIF.
1. Insel, PA. Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout 1991 Gilman, AG, Rall, TW, Nies, AS, Taylor, P eds. Goodman and Gilman's the pharmacological basis of therapeutics McGraw-Hill Singapore 668.
2. Fürst Zs editor. In: Farmakológia. Budapest: Medicina; 2001. p. 845.
3. Houin, G, Tremblay, D, Bree, F, Dufour, A, Ledudal, P, Tillement, JP. The pharmacokinetics and availability of niflumic acid in humans. Int J Clin Pharmacol Ther Toxicol 1983 21:130–134.
4. Lan, SJ, Chando, TJ, Weliky, I, Schreiber, EC. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog. J Pharmacol Exp Ther 1973 186:323–330.
5. Craig, DQM. The mechanisms of drug release from solid dispersions in water soluble polymers. Int J Pharm. 2002;231:131–144 .
6. Leuner, C, Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000 50:47–60 .
7. Chokshia, RJ, Sandhu, HK, Shah, NH, Malick, WA. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution-pros and cons. Drug Deliv 2007 14:33–45 .
8. Patyi, G, Bo′dis, A, Antal, I, Vajna, B, Nagy, Zs, Marosi, Gy. Thermal and spectroscopic analysis of inclusion complex of spironolactone prepared by evaporation and hot melt methods. J Therm Anal Chalorim 2010 102:349–355 .
9. Lutka, A. Investigation of interaction of promethazine with cyclodextrins in aqueous solution. Acta Pol Pharm. 2002;59:45–51.
10. Zielenkiewicz, W, Koźbiał, M, Golankiewicz, B, Poznański, J. Enhancement of aqueous solubility of tricyclic acyclovir derivatives by their complexation with hydroxypropyl-β-cyclodextrin. J Therm Anal Chalorim 2010 101:555–560 .
11. Nisharani, SR, Nilesh, SK, Parth, DM, Arati, NR. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Pharm Dev Technol 2010 15:64–70 .
12. Mashru, RC, Sutariya, VB, Sankalia, MG, Yagnakumar, P. Characterization of solid dispersions of rofecoxib using differential scanning calorimeter. J Therm Anal Calorim 2005 82:167–170 .
13. Tantishaiyakul, V, Keawnopparat, N, Ingkatawornwong, S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm 1999 181:143–151 .
14. Papageorgiou, GZ, Docoslis, A, Georgarakis, M, Bikiaris, D. The effect of physical state on the drug dissolution rate. Miscibility studies of Nimodipine with PVP. J Therm Anal Chalorim 2009 95:903–915 .
15. Taneri, F, Güneri, T, Aigner, Z, Berkesi, O, Kata, M. Thermoanalytical studies on complexes of ketoconazole with cyclodextrin derivatives. J Therm Anal Calorim 2003 74:769–777 .
16. Aigner, Z, Hassan, HB, Berkesi, O, Kata, M, Erős, I. Thermoanalytical, FTIR and X-ray studies of gemfibrozil-cyclodextrin complexes. J Therm Anal Calorim 2005 81:267–272 .
17. Fröming, KH, Szejtli, J Cyclodextrins in pharmacy 1994 Kluwer Academic Publishers Dordrecht 74.
18. Mura, P, Faucci, MT, Bettinetti, GP. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 2001 13:187–194 .
19. Kata, M, Ambrus, R, Aigner, Z. Preparation and investigation of inclusion complexes containing nifluminic acid and cyclodextrins. J Incl Phenom 2002 44:123–126 .
20. Valero, M, Perez-Revuelta, BJ, Rodríguez, LJ. Effect of PVP K-25 on the formation of the naproxen-cyclodextrin complex. Int J Pharm 2003 253:97–110 .
21. Ambrus, R, Aigner, Z, Berkesi, O, Soica, C, Szabó-Révész, P. Determination of structural interaction of nifluminic acid-PVP solid dispersions. Rev Chim 2006 57:1051–1054.
22. Ambrus, R, Aigner, Z, Dehelean, C, Szabó-Révész, P. Physicochemical studies on solid dispersions of nifluminic acid prepared with PVP. Rev Chim 2007 58:60–64.
23. Ambrus, R, Aigner, Z, Soica, C, Peev, C, Szabó-Révész, P. Amorphisation of nifluminic acid with polyvinylpyrrolidone prepared solid dispersion to reach rapid drug release. Rev Chim 2007 58:206–209.
24. Loftsson, T, Frithriksdóttir, H. The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin. Int J Pharm 1998 163:115–121 .
25. Loftsson, T, Masson, M, Sigurjonsdottir, JF. Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma Sci 1999 9:237–242.
26. Esclusa-Diaz, MT, Gayo-Otero, M, Pérez-Marcos, MB, Vila-Jato, JL, Torres-Labandeira, JJ. Preparation and evaluation of ketoconazole-β-cyclodextrin multicomponent complexes. Int J Pharm 1996 142:183–187 .
27. Szente L , Szejtli J. Solution for insolubility problems of base-type drugs: multicomponent cyclodextrin complexation. In: Proceedings of 1st world meeting APGI/APV. Budapest; 1995.
28. Granero, G, Bertorello, MM, Longhi, M. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD. Boll Chim Farm 2002 141:63–66.
29. Patel, AR, Vavia, PR. Effect of hydrophilic polymers on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom 2006 56:247–251 .
30. Patil, JS, Kadam, DV, Marapur, SC, Kamalapur, MV. Inclusion complex system; a novel technique to improve the solubility and bioavailability of poorly soluble drugs: a review. Int J Pharm Sci Rev Res 2010 2 2 29–34.
31. Salomon, JL, Doelker, E. Formulation des comprimés à libération prolongée, I. Matrices inertes. Pharm Acta Helv 1980 55:174–182.
32. Langenbucher, F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972;24:979–989.
33. Socrates, G Infrared characteristic group frequencies—tables and charts 1994 2 Wiley Chichester 80.
34. Allen, RI, Box, KJ, Comer, JEA, Peake, C, Tam, Y. Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs. J Pharm Biomed Anal 1998 17:699–712 .
35. Dannenfelser, RM, Yalkowsky, SH. Database for aqueous solubility of nonelectrolytes. Comput Appl Biosci 1989 5:235–236.